{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:09Z","timestamp":1787062149367,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejogrb.2014.02.034","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T01:23:46Z","timestamp":1393637026000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial"],"prefix":"10.1016","volume":"176","author":[{"given":"Tolga","family":"Ta\u015f\u00e7\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz Emre","family":"\u015e\u00fck\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batuhan","family":"\u00d6zmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem Somer","family":"Atabeko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevim Din\u00e7er","family":"Cengiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evren","family":"Ko\u00e7bulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Berker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"S\u00f6nmezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2014.02.034_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-5122(98)00055-3","article-title":"Estrogen for women at varying risk of coronary disease","volume":"30","author":"Grodstein","year":"1998","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0010","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"issue":"A","key":"10.1016\/j.ejogrb.2014.02.034_bib0025","first-page":"5","article-title":"Cholesterol and lipids in the risk of coronary artery disease \u2013 the Framingham Heart Study","volume":"4","author":"Castelli","year":"1988","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"European Society of Hypertension\u2013European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","author":"European Society of Hypertension\u2013European Society of Cardiology Guidelines Committee","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11883-011-0190-3","article-title":"The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk","volume":"13","author":"Mangalmurti","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0040","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.GME.0000054762.94658.B4","article-title":"Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels","volume":"10","author":"Chiantera","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0045","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1172\/JCI115532","article-title":"Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein-1 synthesis and is abolished by high density lipoprotein","volume":"88","author":"Navab","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0050","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines-chemotactic cytokines that mediate inflammation","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0055","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1136\/hrt.69.1_Suppl.S19","article-title":"Mechanisms of monocyte recruitment and accumulation","volume":"69","author":"Faruqi","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/CS20080581","article-title":"Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications","volume":"117","author":"Niu","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0065","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1172\/JCI115411","article-title":"Monocyte chemoattractant protein-1 in human atheromatous plaques","volume":"88","author":"Nelken","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0046-8177(93)90166-E","article-title":"Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody","volume":"24","author":"Takeya","year":"1993","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0075","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/01.ATV.19.6.1518","article-title":"Monocyte chemotactic protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice","volume":"19","author":"Aiello","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0080","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1073\/pnas.88.12.5252","article-title":"Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions","volume":"88","author":"Yl\u00e4-Herttuala","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0085","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/CIRCULATIONAHA.106.646091","article-title":"Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy","volume":"115","author":"Frangogiannis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0090","first-page":"101","article-title":"Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle","volume":"152","author":"Kolattukudy","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIRCRESAHA.111.243212","article-title":"Inflammation, ER stress, autophagy and MCP-1\/CCR-2 pathway","volume":"110","author":"Kolattukudy","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/092986709788186093","article-title":"Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels","volume":"16","author":"Smiley","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/138955712798995020","article-title":"Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease","volume":"12","author":"Gencel","year":"2012","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0110","series-title":"PASS 11","author":"Hintze","year":"2011"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/157488712799363253","article-title":"Vascular effects of estrogenic menopausal hormone therapy","volume":"7","author":"Reslan","year":"2012","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0015-0282(01)03223-X","article-title":"Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells","volume":"77","author":"Seli","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0125","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.ATV.18.10.1575","article-title":"Estradiol suppresses MCP-1 expression in vivo. Implications for atherosclerosis","volume":"18","author":"Pervin","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0008-6363(01)00461-8","article-title":"The effect of estradiol on MCP-1 serum levels in postmenopausal women","volume":"53","author":"St\u00f6rk","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1172\/JCI5624","article-title":"MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B","volume":"103","author":"Gosling","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0140","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/01.CIR.103.15.1961","article-title":"Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women","volume":"103","author":"Koh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.atherosclerosis.2006.05.045","article-title":"Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene","volume":"193","author":"Christodoulakos","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.amjcard.2005.02.059","article-title":"Effect of transdermal hormone replacement therapy on monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women","volume":"96","author":"Sumino","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.atherosclerosis.2005.12.030","article-title":"Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women","volume":"189","author":"Sumino","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-09-0063","article-title":"Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy","volume":"161","author":"Yasui","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.maturitas.2005.01.004","article-title":"The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis","volume":"52","author":"Eilertsen","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0170","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(00)01623-X","article-title":"Failure of the combination of sequential oral and transdermal estradiol plus norethisterone acetate to affect plasma homocysteine levels","volume":"74","author":"Evi\u00f6","year":"2000","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0015-0282(02)04676-9","article-title":"Effects of estrogen and psychological stress on plasma homocysteine levels","volume":"79","author":"Farag","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0180","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00404-011-2051-2","article-title":"Hormone replacement therapy: relation to homocysteine and prooxidant\u2013antioxidant status in healthy postmenopausal women","volume":"285","author":"G\u00f6kku\u015fu","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/09513590.2010.487610","article-title":"Effects of early initiated oestrogen replacement therapy on plasma homocysteine levels in women in surgically induced menopause","volume":"27","author":"Y\u00fcksel","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0190","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2362.1994.tb01069.x","article-title":"Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women","volume":"24","author":"Van der Mooren","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0195","first-page":"214","article-title":"The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial","volume":"8","author":"Walsh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2014.02.034_bib0200","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S0007114507433013","article-title":"Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women","volume":"97","author":"Friso","year":"2007","journal-title":"Br J Nutr"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211514001055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:31:56Z","timestamp":1759555916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211514001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":40,"alternative-id":["S0301211514001055"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.02.034","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2014.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}